Cargando…

Effect of Mass Azithromycin Distributions on Childhood Growth in Niger: A Cluster-Randomized Trial

IMPORTANCE: Mass azithromycin distributions may decrease childhood mortality, although the causal pathway is unclear. The potential for antibiotics to function as growth promoters may explain some of the mortality benefit. OBJECTIVE: To investigate whether biannual mass azithromycin distributions ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arzika, Ahmed M., Maliki, Ramatou, Ali, Maria M., Alio, Mankara K., Abdou, Amza, Cotter, Sun Y., Varnado, Nicole E., Lebas, Elodie, Cook, Catherine, Oldenburg, Catherine E., O’Brien, Kieran S., Callahan, E. Kelly, Bailey, Robin L., West, Sheila K., Porco, Travis C., Lietman, Thomas M., Keenan, Jeremy D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719241/ https://www.ncbi.nlm.nih.gov/pubmed/34967883 http://dx.doi.org/10.1001/jamanetworkopen.2021.39351

Ejemplares similares

Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR)
por: O’Brien, Kieran S., et al.
Publicado: (2021)

Temporal Trends in Phenotypic Macrolide and Nonmacrolide Resistance for Streptococcus pneumoniae Nasopharyngeal Samples Up to 36 Months after Mass Azithromycin Administration in a Cluster-Randomized Trial in Niger
por: Hazel, Ashley, et al.
Publicado: (2023)

Biannual azithromycin distribution and child mortality among malnourished children: A subgroup analysis of the MORDOR cluster-randomized trial in Niger
por: O’Brien, Kieran S., et al.
Publicado: (2020)

Safety of azithromycin in infants under six months of age in Niger: A community randomized trial
por: Oldenburg, Catherine E., et al.
Publicado: (2018)

Effect of biannual azithromycin distribution on antibody responses to malaria, bacterial, and protozoan pathogens in Niger
por: Arzika, Ahmed M., et al.
Publicado: (2022)

Gut Resistome of Preschool Children After Prolonged Mass Azithromycin Distribution: A Cluster-randomized Trial
por: Arzika, Ahmed M, et al.
Publicado: (2021)

Malaria Parasitemia and Nutritional Status during the Low Transmission Season in the Presence of Azithromycin Distribution among Preschool Children in Niger
por: Arzika, Ahmed M., et al.
Publicado: (2020)

Selection of Macrolide and Non-Macrolide Resistance with Mass Azithromycin Distribution: A Community-Randomized Trial
por: Doan, Thuy, et al.
Publicado: (2020)

Biannual mass azithromycin distributions and malaria parasitemia in pre-school children in Niger: A cluster-randomized, placebo-controlled trial
por: Arzika, Ahmed M., et al.
Publicado: (2019)

Effect of Biannual Mass Azithromycin Distributions to Preschool-Aged Children on Trachoma Prevalence in Niger: A Cluster Randomized Clinical Trial
por: Arzika, Ahmed M., et al.
Publicado: (2022)

Comparison of door-to-door and fixed-point delivery of azithromycin distribution for child survival in Niger: A cluster-randomized trial
por: Arzika, Ahmed M., et al.
Publicado: (2023)

MORDOR II: Persistence of Benefit of Azithromycin for Childhood Mortality
por: Keenan, Jeremy D., et al.
Publicado: (2019)

Optimizing the Number of Child Deaths Averted with Mass Azithromycin Distribution
por: Oldenburg, Catherine E., et al.
Publicado: (2020)

Simplified dosing of oral azithromycin for children 1–11 months old in child survival programmes: age-based and height-based dosing protocols
por: Hu, Huiyu, et al.
Publicado: (2022)

Impact of Biannual Mass Azithromycin Treatment on Enteropathogen Carriage in Children <5 Years Old in Niger
por: Platts-Mills, James A, et al.
Publicado: (2022)

Cause-specific mortality of children younger than 5 years in communities receiving biannual mass azithromycin treatment in Niger: verbal autopsy results from a cluster-randomised controlled trial
por: Keenan, Jeremy D, et al.
Publicado: (2020)

Azithromycin Reduction to Reach Elimination of Trachoma (ARRET): study protocol for a cluster randomized trial of stopping mass azithromycin distribution for trachoma
por: Amza, Abdou, et al.
Publicado: (2021)

Wastewater-Based Surveillance of Antimicrobial Resistance in Niger: An Exploratory Study
por: Ousmane, Sani, et al.
Publicado: (2023)

Mass Azithromycin Distribution to Prevent Childhood Mortality: A Pooled Analysis of Cluster-Randomized Trials
por: Oldenburg, Catherine E., et al.
Publicado: (2019)

Mass Azithromycin and Malaria Parasitemia in Niger: Results from a Community-Randomized Trial
por: O'Brien, Kieran S., et al.
Publicado: (2017)

Efficacy of Mass Azithromycin Distribution for Reducing Childhood Mortality Across Geographic Regions
por: Porco, Travis C., et al.
Publicado: (2020)

Macrolide Resistance in MORDOR I: A Cluster-Randomized Trial in Niger
por: Doan, Thuy, et al.
Publicado: (2019)

Biannual versus annual mass azithromycin distribution and malaria seroepidemiology among preschool children in Niger: a sub-study of a cluster randomized trial
por: Oldenburg, Catherine E., et al.
Publicado: (2019)

Does Mass Azithromycin Distribution Impact Child Growth and Nutrition in Niger? A Cluster-Randomized Trial
por: Amza, Abdou, et al.
Publicado: (2014)

A Cluster-Randomized Controlled Trial Evaluating the Effects of Mass Azithromycin Treatment on Growth and Nutrition in Niger
por: Amza, Abdou, et al.
Publicado: (2013)

Community-level chlamydial serology for assessing trachoma elimination in trachoma-endemic Niger
por: Kim, Jessica S., et al.
Publicado: (2019)

Mass Azithromycin Distribution and Community Microbiome: A Cluster-Randomized Trial
por: Doan, Thuy, et al.
Publicado: (2018)

Mass Oral Azithromycin for Childhood Mortality: Timing of Death After Distribution in the MORDOR Trial
por: Porco, Travis C, et al.
Publicado: (2019)

Molecular detection of intestinal helminths and protozoa among young children in Dosso Region, Niger
por: Aiemjoy, Kristen, et al.
Publicado: (2020)

Neonatal azithromycin administration for prevention of infant mortality
por: Oldenburg, Catherine E., et al.
Publicado: (2022)

Indirect Effect of Azithromycin Use on the Intestinal Microbiome Diversity of Untreated Children: A Randomized Trial
por: Oldenburg, Catherine E, et al.
Publicado: (2019)

Stopping azithromycin mass drug administration for trachoma: A systematic review
por: Mahmud, Hamidah, et al.
Publicado: (2021)

Reduction of Coronavirus Burden With Mass Azithromycin Distribution
por: Doan, Thuy, et al.
Publicado: (2020)

Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: A continuation study of randomly reassigned subclusters (TANA II)
por: Keenan, Jeremy D., et al.
Publicado: (2018)

Neonatal Azithromycin Administration and Growth during Infancy: A Randomized Controlled Trial
por: Sie, Ali, et al.
Publicado: (2023)

Anthropometric Differences in Community- Versus Clinic-Recruited Infants Participating in a Trial of Azithromycin for Prevention of Childhood Mortality in Burkina Faso
por: Ouattara, Mamadou, et al.
Publicado: (2023)

Effect of Single-dose Azithromycin on Pneumococcal Carriage and Resistance: A Randomized Controlled Trial
por: Coulibaly, Boubacar, et al.
Publicado: (2022)

A double-masked placebo-controlled trial of azithromycin to prevent child mortality in Burkina Faso, West Africa: Community Health with Azithromycin Trial (CHAT) study protocol
por: Sié, Ali, et al.
Publicado: (2019)

Optimal Seasonal Timing of Oral Azithromycin for Malaria
por: Gao, Daozhou, et al.
Publicado: (2014)

Mass azithromycin distribution for reducing childhood mortality in sub-Saharan Africa
por: Keenan, Jeremy D, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mrifpgjicuk8tfh5aolipqiupg